Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF CASH FLOWS

v3.21.2
CONDENSED STATEMENT OF CASH FLOWS
8 Months Ended
Sep. 30, 2021
USD ($)
Cash Flows from Operating Activities:  
Net income $ 3,780,286
Adjustments to reconcile net income to net cash used in operating activities:  
Interest earned on marketable securities held in Trust Account (2,851)
Change in fair value of warrant liabilities (4,522,500)
Transaction costs allocated to warrants 329,619
Changes in operating assets and liabilities:  
Prepaid expenses (714,605)
Accrued expenses 216,216
Net cash used in operating activities (913,835)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (172,500,000)
Net cash used in investing activities (172,500,000)
Cash Flows from Financing Activities:  
Proceeds from issuance of Class B common stock to Sponsor 25,000
Proceeds from sale of Units, net of underwriting discounts paid 169,050,000
Proceeds from sale of Private Placements Warrants 5,700,000
Proceeds from promissory note - related party 46,975
Repayment of promissory note - related party (46,975)
Payment of offering costs (440,025)
Net cash provided by financing activities 174,334,975
Net Change in Cash 921,140
Cash - Beginning of period 0
Cash - End of period 921,140
Non-Cash investing and financing activities:  
Offering costs included in accrued offering costs 20,274
Initial value of common stock subject to possible redemption 172,500,000
Deferred underwriting fee payable $ 6,037,500